I don't usually mention my basket-case shares as they forever shift in value by high percentages, but I should mention my biggest basket-case KIBO:Kibo Energy, which did an utterly massive placing this week and replaced the board. This resulted in a 57% drop, but it makes no difference to my holding as it's already 100% down and the commission to sell is more than the shares are worth. Unfortunately when I finally write them off it's going result in me posting a £2.6k loss and undo much of the good that's going on elsewhere.
AFC:AFC Energy is up and down like a mad thing. This week it dropped 15% for no reason. I think I may want to introduce it to my trading account and try and ride some of these extreme changes.
PAF:Pan African Resources dropped 6% this week. POLY:Polymetal dropped 5% and although the other gold mines all fell in value, they were less than 5% drops.
AAL:Anglo American Mining is one of my new copper producers, but they dropped 5% this week The CAML:Central Asia Metals shares I sold to buy them dropped 4% so I'm not much worse off.
ASHM:Ashmore Group also dropped 5% in a generally miserable week.
SBTX:SkinBioTherapeutics recovered a little from its recent woes and went up 6%, but needs news on Croda deals to properly recover.
Share of the Week is FXPO:Ferrexpo which almost qualifies as a basket-case share, but I'm confident it will recover once the Ukraine war is out of the way. They went up 8% this week and have been very volatile lately, so maybe another to consider for the trading account.
Here's the ISA and shares portfolio after week 45 of year 9.
| Weekly Change | |||
| Cash | £3.81 | -£3.75 | |
| Portfolio cost | £104,466.12 | +£0 | |
| Portfolio sell value (bid price-commission) | £47,679.20 | (-54.4%) | -£1,023.95 |
| Potential profits | £1,965.78 | -£426.00 | |
| Yr 9 Dividends | £296.50 | +£0 | |
| Yr 9 Interest | £4.14 | +£0 | |
| Yr 9 Profit from sales | £536.46 | +£0 | |
| Yr 9 proj avg monthly profit | £73.28 | (1.2%) | -£2.03 |
| Total Dividends | £12,207.93 | +£0 | |
| Total Interest | £6.07 | +£0 | |
| Total Profit from sales | £17,834.99 | +£0 | |
| Average monthly cash profit | £278.19 | (4.4%) | -£0.64 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 39% | +0% |
Very little happened. Cash down thanks to monthly fees and the usual 4-figure drop in value. OPTI:Optibiotix dropped 0.5p which contributed much of the drop, and JLP:Jubilee Metals is down 0.1p.
The decline continues
The trend line is dropping ever more steeply.
The SIPP looks like this after week 445 overall and week 29 of year 9.
| Weekly Change | ||||
| Cash | £524.68 | +£52.74 | ||
| Portfolio cost | £110,306.85 | +£338.75 | ||
| Portfolio sell value (bid price - commission) | £56,119.76 | (-49.1%) | -£1,370.35 | |
| Potential profits | £2,480.10 | -£564.45 | ||
| Yr 9 Dividends | £681.35 | +£0 | ||
| Yr 9 Interest | £2.81 | +£0 | ||
| Yr 9 Profit from sales | £4,934.96 | +£188.72 | ||
| Yr 9 proj avg monthly profit | £820.54 | (13.5%) | -£2.67 | |
| Total Dividends | £15,316.23 | +£0 | ||
| Total Interest | £8.74 | +£0 | ||
| Total Profit from sales | £15,770.86 | +£188.72 | ||
| Average monthly cash profit | £290.29 | (4.8%) | +£1.02 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 41% | +0% |
I sold another 500 CAML:Central Asia Metals shares at 219.165p, making £188.72 (20.8%) profit. I did so to free up funds to buy GSK:GSK, which fell 10% after news that an American judge had allowed some court cases against their Zantac drug. However, a court case the other week threw out a claim as there was no scientific evidence to back it, so it seems there's a precedent been set. I've wanted to add these to my SIPP for ages and this seemed like a good opportunity. I bought 65 shares at 1603.31p costing £1,056.31, and am happy to say they went up 2% and so now are just down by some of the commission.
I also bought my rights offer shares in NG.:National Grid. 28 shares at 645p costing £180.60, with no commission charges. That brings my weighted average down to 933.8562p, meaning my shares are down 9% on when I bought them, which is better performance than most things I buy.
Portfolio value is mainly down for the same reasons as the ISA, but also all my gold and metal shares, and potential profits are down because of my sale, but also the same drops in gold and metal shares.
Still horrid.
Amazingly the trend line is still pointing upwards, but not for much longer.
Still horrid.
Amazingly the trend line is still pointing upwards, but not for much longer.
The trading account looks like this after week 411 overall and week 47 of year 8.
A tiny drop in JLP:Jubilee Metals was mitigated by the rise in SBTX:SkinBioTherapeutics so there was very little change.
I really need some news on the Roan copper upgrade from JLP:Jubilee Metals, as it was meant to be completed at the end of May, but it's looking increasingly like it wasn't done on time.
Still well north of the trend line, which is pointing upwards, so shouldn't complain really.
I won't sell any more CAML:Central Asia Metals now, as there are no burning desires to add anything else to my SIPP. It's nice to have diversified a little, but I do want to build my CAML holding back up again, as they have so much cash that either an acquisition or special dividend seem likely soon. I get another £2k transfer at the end of June so will use all that for CAML, and I have £5k of JLP:Jubilee Metals to sell when the Roan news comes out, much of which is destined for CAML.
| Weekly Change | |||
| Cash | £63.39 | +£0 | |
| Portfolio cost | £2,073.87 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,538.83 | (-25.8%) | -£5.93 |
| Potential profits | £124.56 | -£8.53 | |
| Year 8 Dividends | £25.36 | +£0 | |
| Year 8 Interest | £0 | +£0 | |
| Year 8 Profit | £328.15 | +£0 | |
| Yr 8 proj avg monthly profit | £32.59 | (+18.9%) | -£0.71 |
| Dividends | £85.46 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£602.54 | +£0 | |
| Average monthly cash profit | -£5.45 | (-3.2%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
A tiny drop in JLP:Jubilee Metals was mitigated by the rise in SBTX:SkinBioTherapeutics so there was very little change.
I really need some news on the Roan copper upgrade from JLP:Jubilee Metals, as it was meant to be completed at the end of May, but it's looking increasingly like it wasn't done on time.
Still well north of the trend line, which is pointing upwards, so shouldn't complain really.
I won't sell any more CAML:Central Asia Metals now, as there are no burning desires to add anything else to my SIPP. It's nice to have diversified a little, but I do want to build my CAML holding back up again, as they have so much cash that either an acquisition or special dividend seem likely soon. I get another £2k transfer at the end of June so will use all that for CAML, and I have £5k of JLP:Jubilee Metals to sell when the Roan news comes out, much of which is destined for CAML.
No comments:
Post a Comment